Rx Item-Cosentyx SECUKINUMAB 150Mg/Ml Inj 2 By Novartis

COSENTYX- secukinumab injection
Novartis Pharmaceuticals Corporation

1 INDICATIONS AND USAGE

? 1.1 Plaque Psoriasis
COSENTYX� is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.

? 1.2 Psoriatic Arthritis
? COSENTYX is indicated for the treatment of adult patients with active psoriatic arthritis.

? 1.3 Ankylosing Spondylitis


? COSENTYX is indicated for the treatment of adult patients with active ankylosing spondylitis.

2 DOSAGE AND ADMINISTRATION

? 2.1 Plaque Psoriasis
The recommended dosage is 300 mg by subcutaneous injection at Weeks 0, 1, 2, 3, and 4 followed by 300 mg every 4 weeks. Each 300 mg dosage is given as 2 subcutaneous injections of 150 mg.

For some patients, a dosage of 150 mg may be acceptable.

? 2.2 Psoriatic Arthritis
? For psoriatic arthritis patients with coexistent moderate to severe plaque psoriasis, use the dosing and administration recommendations for plaque psoriasis [see Dosage and Administration (2.1)].

? For other psoriatic arthritis patients, administer COSENTYX with or without a loading dosage by subcutaneous injection. The recommended dosage:

? With a loading dosage is 150 mg at weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter
? Without a loading dosage is 150 mg every 4 weeks
? If a patient continues to have active psoriatic arthritis, consider a dosage of 300 mg.
? COSENTYX may be administered with or without methotrexate.

? 2.3 Ankylosing Spondylitis
? Administer COSENTYX with or without a loading dosage by subcutaneous injection. The recommended dosage:

? With a loading dosage is 150 mg at weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter
? Without a loading dosage is 150 mg every 4 weeks

RX ITEM-Cosentyx 150Mg/Ml Inj 2 By Novar
Cosentyx SECUKINUMAB 150Mg/Ml Inj 2 By Novartis item No.:RX380584 NDC No.78063941 UPC No.:300780639415 NDC No. 00078-0639-41 00078-639-41 0007863941 00078063941 UPC/GTIN No. 3-00780-63941-5 300780639

Cosentyx 150Mg/Ml Inj 2 By Novartis
BRAND: COSENTYX NDC: 00078-0639-41,78063941 UPC: 3-00780-63941-5,300780639415 Novartis Pharma Corp

SECUKINUMAB SUB-Q PEN INJ
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.